Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
10.76
-0.50 (-4.44%)
At close: Aug 15, 2025, 3:59 PM
10.78
0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aardvark Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
92K 140K 137K 162K 101K 53K 51K 26K
Gross Profit
-92K -140K -137K -162K -101K -53K -51K -26K
Operating Income
-40.86M -31.08M -22.79M -15.57M -12.2M -6.12M -3.95M -1.72M
Interest Income
2.89M 3.49M 2.41M 1.81M 950K 356K 253K 135K
Pretax Income
-36.64M -27.72M -20.59M -13.85M -11.78M -6.33M -4.15M -2.11M
Net Income
-36.64M -27.72M -20.59M -13.85M -11.78M -6.33M -4.15M -2.11M
Selling & General & Admin
7.83M 7.16M 5.3M 4.44M 3.95M 1.92M 1.06M 538K
Research & Development
33.03M 23.91M 17.36M 10.84M 7.74M 3.71M 2.5M 964K
Other Expenses
n/a 14K 117K 288K 505K 491K 388K 217K
Operating Expenses
40.86M 31.08M 22.79M 15.57M 12.2M 6.12M 3.95M 1.72M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
40.86M 31.08M 22.79M 15.57M 12.2M 6.12M 3.95M 1.72M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
21.69M 13.19M 12.91M 12.91M 2.56M 12.91M 9.73M 9.73M
Shares Outstanding (Diluted)
21.69M 13.19M 12.91M 12.91M 2.56M 12.91M 9.73M 9.73M
EPS (Basic)
-2.37 -3.84 -3.3 -2.83 -2.73 -0.6 -0.43 -0.22
EPS (Diluted)
-2.37 -3.84 -3.3 -2.83 -2.73 -0.6 -0.43 -0.22
EBITDA
-40.77M -30.95M -22.65M -15.21M -11.69M -5.66M -3.49M -1.48M
EBIT
-38.22M -29.92M -22.79M -15.38M -11.79M -5.71M -3.54M -1.5M
Depreciation & Amortization
100K 148K 145K 162K 101K 53K 51K 26K